Roles of Fc receptors in autoimmunity (original) (raw)

• Sinclair, N. R., Lees, R. K. & Elliott, E. V. Role of the Fc fragment in the regulation of the primary immune response. Nature 220, 1048–1049 (1968).
  Article CAS PubMed Google Scholar
• Sinclair N. R. Fc-signalling in the modulation of immune responses by passive antibody. Scand. J. Immunol. 53, 322–330 (2001).This paper provides an historical overview of antibody-mediated activation and suppression of immune responses.
  Article CAS PubMed Google Scholar
• Paraskevas, F., Lee, S. T., Orr, K. B. & Israels, G. A receptor for Fc on mouse B lymphocytes. J. Immunol. 108, 1319–1327 (1972).
  CAS PubMed Google Scholar
• Amigorena, S. & Bonnerot, C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol. Rev. 172, 279–284 (1999).
  Article CAS PubMed Google Scholar
• Fridman, W. H. et al. Structural bases of Fcγ receptor functions. Immunol. Rev. 125, 49–76 (1992).
  Article CAS PubMed Google Scholar
• Durum, S. K., Lee, C.-K., Geiman, T. M., Murphy, W. J. & Muegge, K. CD16 cross-linking blocks rearrangement of the TCRβ locus and development of αβ T cells and induces development of NK cells from thymic progenitors. J. Immunol. 161, 3325–3329 (1998).
  CAS PubMed Google Scholar
• de Andres, B., Mueller, A. L., Verbeek, S., Sandor, M. & Lynch, R. G. A regulatory role for Fcγ receptors CD16 and CD32 in the development of murine B cells. Blood 92, 2823–2829 (1998).
  CAS PubMed Google Scholar
• Kato, I., Takai, T. & Kudo, A. FcγRIIB negatively regulates the pre-BCR signaling for apoptosis. J. Immunol. 168, 629–634 (2002).
  Article CAS PubMed Google Scholar
• Takai, T., Li, M., Sylvestre, D., Clynes, R. & Ravetch, J. V. FcR γ-chain deletion results in pleiotrophic effector-cell defects. Cell 76, 519–529 (1994).Describes multiple immune-system defects in FcRγ-deficient mice.
  Article CAS PubMed Google Scholar
• Sylvestre, D. L. & Ravetch, J. V. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265, 1095–1098 (1994).Opens the discussion on the dominant role of Fc receptors over complement.
  Article CAS PubMed Google Scholar
• Clynes, R. & Ravetch, J. V. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3, 21–26 (1995).
  Article CAS PubMed Google Scholar
• Clynes, R. et al. Modulation of immune-complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189, 179–186 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sylvestre, D. L. & Ravetch, J. V. A dominant role for mast-cell Fc receptors in the Arthus reaction. Immunity 5, 387–390 (1996).
  Article CAS PubMed Google Scholar
• Hazenbos, W. L. W. et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16)-deficient mice. Immunity 5, 181–188 (1996).The first description of the phenotypes of FcγRIII-deficient mice.
  Article CAS PubMed Google Scholar
• Ujike, A. et al. Modulation of IgE-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189, 1573–1579 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Barnes, N. et al. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16, 379–389 (2002).
  Article CAS PubMed Google Scholar
• Ioan-Facsinay, A. et al. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16, 391–402 (2002).References 16 and 17 describe several noteworthy aspects of FcγRI-deficient mice.
  Article CAS PubMed Google Scholar
• Takai, T., Ono, M., Hikida, M., Ohmori, H. & Ravetch, J. V. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379, 346–349 (1996).The first description of FcγRIIb-deficient mice, showing that FcγRIIb is an inhibitory receptor in vivo.
  Article CAS PubMed Google Scholar
• van de Winkel, J. G. J. & Capel, P. J. A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 14, 215–221 (1993).
  Article CAS PubMed Google Scholar
• Shibuya, A. et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nature Immunol. 1, 441–446 (2000).
  Article CAS Google Scholar
• Launay, P. et al. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor–IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191, 1999–2009 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• McDonald, K. J., Cameron, A. J., Allen, J. M. & Jardine, A. G. Expression of Fcα/μ receptor by human mesangial cells: a candidate receptor for immune-complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290, 438–442 (2002).
  Article CAS PubMed Google Scholar
• Davis, R. S., Wang, Y.-H., Kubagawa, H. & Cooper, M. D. Identification of a family of Fc-receptor homologs with preferential B-cell expression. Proc. Natl Acad. Sci. USA 98, 9772–9777 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hatzivassiliou, G. et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B-cell malignancy. Immunity 14, 277–289 (2001).
  Article CAS PubMed Google Scholar
• Rigby, L. J. et al. Domain one of the high-affinity IgE receptor, FcɛRI, regulates binding to IgE through its interface with domain two. J. Biol. Chem. 275, 9664–9672 (2000).
  Article CAS PubMed Google Scholar
• Rigby, L. J. et al. Monoclonal antibodies and synthetic peptides define the active site of FcγRI and a potential receptor antagonist. Allergy 55, 609–619 (2000).
  Article CAS PubMed Google Scholar
• Sondermann, P., Huber, R., Oosthuizen, V. & Jacob, U. The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex. Nature 406, 267–273 (2000).Detailed three-dimensional structural analysis of the FcγR–IgG interaction, providing an insight into the unique binding stoichiometry of FcγRs and IgG.
  Article CAS PubMed Google Scholar
• Takai, T. & Ravetch, J. V. In Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity (eds van de Winkel, J. G. J. & Hogarth, P. M.) 37–48 (Kluwer Academic Publishers, Netherlands, 1998).
  Book Google Scholar
• Ravetch, J. V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84–89 (2000).Provides an intriguing overview of inhibitory receptors in Fc- and NK-receptor families.
  Article CAS PubMed Google Scholar
• Takai, T. & Ono, M. Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol. Rev. 181, 215–222 (2001).
  Article CAS PubMed Google Scholar
• Ravetch, J. V. & Clynes, R. A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16, 421–432 (1998).An excellent review of the crucial roles of Fc receptors in immunity.
  Article CAS PubMed Google Scholar
• Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275–290 (2001).
  Article CAS PubMed Google Scholar
• Wang, A. V., Scholl, P. R. & Geha, R. S. Physical and functional association of the high-affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn. J. Exp. Med. 180, 1165–1170 (1994).
  Article CAS PubMed Google Scholar
• Ghazizadeh, S., Bolen, J. B. & Fleit, H. B. Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells. J. Biol. Chem. 269, 8878–8884 (1994).
  CAS PubMed Google Scholar
• Pricop, L. et al. Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by TH1 and TH2 cytokines. J. Immunol. 166, 531–537 (2001).
  Article CAS PubMed Google Scholar
• Kwiatkowska, K. & Sobota, A. The clustered Fcγ receptor II is recruited to Lyn-containing membrane domains and undergoes phosphorylation in a cholesterol-dependent manner. Eur. J. Immunol. 31, 989–998 (2001).
  Article CAS PubMed Google Scholar
• Muta, T. et al. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell-receptor signalling. Nature 368, 70–73 (1994).
  Article CAS PubMed Google Scholar
• D'Ambrosio, D. et al. Recruitment and activation of PTP-1C in negative regulation of antigen-receptor signaling by FcγRIIB1. Science 268, 293–297 (1995).
  Article CAS PubMed Google Scholar
• Damen, J. E. et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl Acad. Sci. USA 93, 1689–1693 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Ono, M., Bolland, S., Tempst, P. & Ravetch, J. V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383, 263–266 (1996).Demonstrates, for the first time, the recruitment of SHIP to FcγRIIB.
  Article CAS PubMed Google Scholar
• Ono, M. et al. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90, 293–301 (1997).
  Article CAS PubMed Google Scholar
• Fong, D. C. et al. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast-cell activation. Immunol. Lett. 54, 83–91 (1996).
  Article CAS PubMed Google Scholar
• Gupta, N. et al. Negative signaling pathways of the killer-cell inhibitory receptor and FcγRIIb1 require distinct phosphatases. J. Exp. Med. 186, 473–478 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Nakamura, K., Brauweiler, A. & Cambier, J. C. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on FcγRIIB1-effector interactions and inhibitory functions. J. Immunol. 164, 631–638 (2000).
  Article CAS PubMed Google Scholar
• Scharenberg, A. M. et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17, 1961–1972 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Fluckiger, A. C. et al. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell-receptor activation. EMBO J. 17, 1973–1985 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Bolland, S., Pearse, R. N., Kurosaki, T. & Ravetch, J. V. SHIP modulates immune-receptor responses by regulating membrane association of Btk. Immunity 8, 509–516 (1998).
  Article CAS PubMed Google Scholar
• Liu, Q. et al. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B-cell antigen-receptor signaling. J. Exp. Med. 188, 1333–1342 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T. & Ravichandran, K. S. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 273, 33922–33928 (1998).
  Article CAS PubMed Google Scholar
• Helgason, C. D. et al. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of B lymphocytes in _Ship_−/− mice. J. Exp. Med. 191, 781–794 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Tridandapani, S. et al. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcγ immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17, 4305–4311 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Tamir, I. et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12, 347–358 (2000).
  Article CAS PubMed Google Scholar
• Tridandapani, S., Chacko, G. W., Van Brocklyn, J. R. & Coggeshall, K. M. Negative signaling in B cells causes reduced Ras activity by reducing Shc–Grb2 interactions. J. Immunol. 158, 1125–1132 (1997).
  CAS PubMed Google Scholar
• Hashimoto, A. et al. Involvement of guanosine triphosphatases and phospholipase C-γ2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B-cell antigen receptor. J. Exp. Med. 188, 1287–1295 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Yamanashi, Y. et al. Role of the rasGAP-associated docking protein p62dok in negative regulation of B-cell-receptor-mediated signaling. Genes Dev. 14, 11–16 (2000).Demonstrates the crucial role of Dok in FcγRIIb-mediated B-cell inhibition using Dok-deficient mice.
  CAS PubMed PubMed Central Google Scholar
• Hippen, K. L. et al. FcγRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7, 49–58 (1997).
  Article CAS PubMed Google Scholar
• Ashman, R. F., Peckham, D. & Stunz, L. L. Fc receptor off-signal in the B cell involves apoptosis. J. Immunol. 157, 5–11 (1996).
  CAS PubMed Google Scholar
• Pearse, R. N. et al. SHIP recruitment attenuates FcγRIIB-induced B-cell apoptosis. Immunity 10, 753–760 (1999).Introduces the unexpected role of FcγRIIB in inducing apoptosis in B cells.
  Article CAS PubMed Google Scholar
• Regnault, A. et al. Fcγ-receptor-mediated induction of dendritic-cell maturation and major histocompatibility complex class-I-restricted antigen presentation after immune-complex internalization. J. Exp. Med. 189, 371–380 (1999).Provides evidence of the important role of FcγRs on dendritic cells for the enhancement of antigen presentation.
  Article CAS PubMed PubMed Central Google Scholar
• Booth, J. W., Kim, M.-K., Jankowski, A., Schreiber, A. D. & Grinstein, S. Contrasting requirements for ubiquitylation during Fc-receptor-mediated endocytosis and phagocytosis. EMBO J. 21, 251–258 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Machy, P., Serre, K. & Leserman, L. Class-I-restricted presentation of exogenous antigen acquired by Fcγ-receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30, 848–857 (2000).
  Article CAS PubMed Google Scholar
• Hamano, Y., Arase, H., Saisho, H. & Saito, T. Immune complex and Fc-receptor-mediated augmentation of antigen presentation for in vivo TH-cell responses. J. Immunol. 164, 6113–6119 (2000).
  Article CAS PubMed Google Scholar
• Watanabe, N. et al. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor-necrosis factor production upon triggering Fcγ receptors. Blood 94, 3855–3863 (1999).
  CAS PubMed Google Scholar
• Hazenbos, W. L. W. et al. Murine IgG1 complexes trigger immune effector functions predominantly via FcγRIII (CD16). J. Immunol. 161, 3026–3032 (1998).
  CAS PubMed Google Scholar
• Clynes, R., Dumitru, C. & Ravetch, J. V. Uncoupling of immune-complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052–1054 (1998).
  Article CAS PubMed Google Scholar
• Suzuki, Y. et al. Distinct contribution of Fc receptors and angiotensin-II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. 54, 1166–1174 (1998).
  Article CAS PubMed Google Scholar
• Park, S. Y. et al. Resistance of Fc-receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102, 1229–1238 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Dombrowicz, D. et al. Absence of FcɛRI α-chain results in upregulation of FcγRIII-dependent mast-cell degranulation and anaphylaxis. Evidence of competition between FcɛRI and FcγRIII for limiting amounts of FcR β- and γ-chain. J. Clin. Invest. 99, 915–925 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Dombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H. & Kinet, J.-P. Abolition of anaphylaxis by targeted disruption of the high-affinity immunoglobulin E receptor α-chain gene. Cell 75, 969–976 (1993).
  Article CAS PubMed Google Scholar
• Schiller, C. et al. Mouse FcγRII is a negative regulator of FcγRIII in IgG immune-complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur. J. Immunol. 30, 481–490 (2000).
  Article CAS PubMed Google Scholar
• Kleinau, S., Martinsson, P. & Heyman, B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J. Exp. Med. 191, 1611–1616 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Yuasa, T. et al. Deletion of FcγRIIB renders H-2b mice susceptible to collagen-induced arthritis. J. Exp. Med. 189, 187–194 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, Y. et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51, 429–435 (2000).
  Article CAS PubMed Google Scholar
• Pritchard, N. R. et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10, 227–230 (2000).
  Article CAS PubMed Google Scholar
• Courtenay, J. S., Dallman, M. J., Dayan, A. D., Marten, A. & Mosedale, B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666–668 (1980).
  Article CAS PubMed Google Scholar
• Svensson, L., Jirholt, J., Holmdahl, R. & Jansson, L. B-cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111, 521–526 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Stuart, J. M. & Dixon, F. J. (1983) Serum transfers of collagen-induced arthritis in mice. J. Exp. Med. 158, 378–392 (1983).
  Article CAS PubMed Google Scholar
• Wooley, P. H., Luthra, H. S., Stuart, J. M. & David, S. C. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J. Exp. Med. 154, 688–700 (1981).
  Article CAS PubMed Google Scholar
• Holmdahl, R. et al. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 118, 193–232 (1990).
  Article CAS PubMed Google Scholar
• Kalluri, R. Goodpasture syndrome. Kidney Int. 55, 1120–1122 (1999).
  Article CAS PubMed Google Scholar
• Savage, C. O., Pusey, C. D., Bowman, C., Rees, A. J. & Lockwood, C. M. Antiglomerular basement membrane antibody-mediated disease in the British Isles. Br Med J (Clin Res Ed) 292, 301–304 (1986).
  Article CAS Google Scholar
• Nakamura, A. et al. Fcγ-receptor-IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. 191, 899–906 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bolland, S. & Ravetch, J. V. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277–285 (2000).References 12, 71, 72, 82 and 83 describe the direct relationship of FcγRIIb defects with different types of autoimmunity.
  Article CAS PubMed Google Scholar
• Bolland, S., Yim, Y.-S., Tus, K., Wakeland, E. K. & Ravetch, J. V. Genetic modifiers of systemic lupus erythematosus in FcγRIIB−/− mice. J. Exp. Med. 195, 1167–1174 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Luan, J. J. et al. Defective FcγRII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. J. Immunol. 157, 4707–4716 (1996).
  CAS PubMed Google Scholar
• Jordan, M. A. et al. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J. Immunol. 165, 1673–1684 (2000).
  Article CAS PubMed Google Scholar
• Myhr, K. M., Raknes, G., Nyland, H. & Vedeler, C. Imunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS. Neurology 52, 1771–1776 (1999).
  Article CAS PubMed Google Scholar
• Abdul-Majid, K.-B. et al. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55, 70–81 (2002).Indicates the importance of FcγRs to T-cell-mediated autoimmunity, such as EAE.
  Article CAS PubMed Google Scholar
• Bakker, A. B. H. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345–353 (2000).
  Article CAS PubMed Google Scholar
• Tomasello, E. et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13, 355–364 (2000).
  Article CAS PubMed Google Scholar
• Kyogoku, C. et al. Association of Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to the genetic susceptibility to SLE. Arthritis Rheum. 46, 1242–1254 (2002).Describes FcγRIIB polymorphisms and their relation to SLE.
  Article CAS PubMed Google Scholar
• Salmon, E. & Kimberly, R. P. In The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity (eds van de Winkel, J. G. J. & Hogarth, P. M.) 267–278 (Kluwer Academic Publishers, Great Britain, 1998).
  Book Google Scholar
• Salmon, J. E. & Pricop, L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 44, 739–750 (2001).
  Article CAS PubMed Google Scholar
• Duits, A. J. et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 38, 1832–1836 (1995).
  Article CAS PubMed Google Scholar
• Salmon, J. E. et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97, 1348–1354 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Song, Y. W. et al. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 41, 421–426 (1998).
  Article CAS PubMed Google Scholar
• Koene, H. R. et al. The FcγRIIIA–158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 41, 1813–1818 (1998).
  Article CAS PubMed Google Scholar
• Wu, J. et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100, 1059–1070 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Salmon, J. E., Kimberly, R. P., Gibofsky, A. & Fotino, M. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc-receptor ligand binding and internalization. J. Immunol. 133, 2525–2531 (1984).
  CAS PubMed Google Scholar
• Hatta, Y. et al. Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA, polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. 1, 53–60 (1999).
  Article CAS PubMed Google Scholar
• Nieto, A. et al. Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum. 43, 735–739 (2000).
  Article CAS PubMed Google Scholar
• Wainstein, E. et al. The neutrophil FcγRIIIB is associated with renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum. 39, S210 (1996).
  Google Scholar
• Vedeler, C. A., Raknes, G., Myhr, K. M. & Nyland, H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology 55, 705–707 (2000).
  Article CAS PubMed Google Scholar
• Botto, M. et al. FγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin. Exp. Immunol. 104, 264–268 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, M. et al. Frequency of the _FcγRIIIA_–158F allele in African American patients with systemic lupus erythematosus. J. Rheumatol. 26, 1486–1489 (1999).
  CAS PubMed Google Scholar
• Tax, W. J. M., Willems, H. W., Reekers, P. P. M., Capel, P. J. A. & Koene, R. A. P. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304, 445–447 (1983).
  Article CAS PubMed Google Scholar
• Lalezari, P. In Immunohaematology (eds Engelfreet, C. P., Van Loghem, J. J., Kr, A. E. G.) 33 (Elsevier Science, Amsterdam, 1984).
  Google Scholar
• Salmon, J. E., Edberg, J. C. & Kimberly, R. P. Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 85, 1287–1295 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Yasuda, K., Sugita, N., Yamamoto, K., Kobayashi, T. & Yoshie, H. Seven single nucleotide substitutions in human Fcγ receptor IIB gene. Tissue Antigens 58, 339–342 (2001).
  Article CAS PubMed Google Scholar
• Gelfand, E. W. Antibody-directed therapy: past, present and future. J. Allergy Clin. Immunol. 108, S111–S116 (2001).
  Article CAS PubMed Google Scholar
• Samuelsson, A., Towers, T. & Ravetch, J. V. Anti-inflammaotry activity of IVIG mediated through the inhibitory Fc receptor. Science 291, 484–486 (2001).Describes the intriguing observation of FcγRIIb upregulation in macrophages after IVIG treatment in mice.
  Article CAS PubMed Google Scholar
• Yamazaki, T. et al. Essential immunoregulatory role for BCAP in B-cell development and function. J. Exp. Med. 195, 535–545 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Wagle, N. M., Faassen, A. E., Kim, J. H. & Pierce, S. K. Regulation of B-cell-receptor-mediated MHC class II antigen processing by FcγRIIB1. J. Immunol. 162, 2732–2740 (1999).
  CAS PubMed Google Scholar
• Rudge, E. R., Cutler, A. J., Pritchard, N. R. & Smith, K. G. C. Interleukin-4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B-cell suppression. J. Exp. Med. 195, 1079–1085 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Dombrowicz, D. et al. Allergy-associated FcRβ is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 8, 517–529 (1998).
  Article CAS PubMed Google Scholar
• Yu, P., Kosco-Vilbois, M., Richards, M., Kohler, G. & Lamers, M. C. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369, 753–756 (1994).
  Article CAS PubMed Google Scholar
• Israel, E. J., Wilsker, D. F., Hayes, K. C., Schoenfeld, D. & Simister, N. E. Increased clearance of IgG in mice that lack β2-microglobulin: possible protective role of FcRn. Immunology 89, 573–578 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Christianson, G. J. et al. β2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J. Immunol. 159, 4781–4792 (1997).
  CAS PubMed Google Scholar
• Shimada, S. et al. Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J. Immunol. 163, 5367–5373 (1999).
  CAS PubMed Google Scholar
• de Haas, M., Kleijer, M., van Zwieten, R., Roos, D. & von dem Borne, A. E. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 86, 2403–2413 (1995).
  CAS PubMed Google Scholar
• van de Winkel, J. G., de Wit, T. P., Ernst, L. K., Capel, P. J. & Ceuppens, J. L. Molecular basis for a familial defect in phagocyte expression of IgG receptor I (CD64). J. Immunol. 154, 2896–2903 (1995).
  CAS PubMed Google Scholar